Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Gynecologic 1

Conditions

Carcinoma, Merkel Cell 2Uveal Melanoma 1Melanoma 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interferon-beta × Dermatologic × Clear all
NCT02584829 2022-03-22

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
8 enrolled 16 charts
Dermatologic

Carcinoma, Merkel Cell

NCT01758458 2017-04-19

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
4 enrolled
Dermatologic

Carcinoma, Merkel Cell

NCT00085306 2015-10-02

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Case Comprehensive Cancer Center

Phase 2 Completed
21 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡